Neovasc to Present at the Canaccord Genuity 35th Annual Growth Conference

Aug 11, 2015, 14:19 ET from Neovasc Inc.


VANCOUVER, Aug. 11, 2015 /PRNewswire/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN) (TSX: NVC) today announced that CEO Alexei Marko is scheduled to present at the Canaccord Genuity 35th Annual Growth Conference on Wednesday, August 12th at 9:30 am ET in Boston, MA.

A live audio webcast of the presentation will be available on the Investors page of Neovasc's website at

About Neovasc Inc.  Neovasc is a specialty medical device company that develops, manufactures and markets products for the rapidly growing cardiovascular marketplace.  Its products in development include Tiara™, for the transcatheter treatment of mitral valve disease and the Neovasc Reducer™ for the treatment of refractory angina. The Company also sells a line of advanced biological tissue products that are used as key components in third-party medical products including transcatheter heart valves. For more information, visit:

SOURCE Neovasc Inc.